Pharmacist-Driven Therapeutic Infliximab Monitoring at the Point of Care Using Rapidly Assessed Drug Levels in Patients with Inflammatory Bowel Disease.

Clarissa A Rentsch,Mark G Ward,Raphael P Luber,Kirstin M Taylor,David J Gibson,Belinda Headon,Ourania Rosella,Heidi Y Su,Antony B Friedman,Michael Dooley,Miles P Sparrow,Peter R Gibson

Therapeutic drug monitoring（2023）

Cited 1|Views21

No score

Abstract

Immediate dose adjustment after infliximab rapid assay performed by a pharmacist using a sliding scale is a feasible strategy. Supratherapeutic infliximab levels can be safely and quickly brought into the therapeutic range using small dose adjustments without affecting disease activity, offsetting (at least partly) costs associated with dose escalation.

Translated text

Key words

infliximab, rapid test, proactive, therapeutic drug monitoring, Crohn disease, ulcerative colitis, pharmacist-driven intervention

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined